• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP HI-LITE ORANGE; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP HI-LITE ORANGE; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 930815
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Abrasion (1689)
Event Date 02/02/2022
Event Type  Injury  
Event Description
It was reported that chloraprep ampoule shattered.Verbatim: chloraprep *not enough info provided* we were notified of a complaint from a customer stating that the chloraprep ampoule shattered.If it is indicated that a sample is available please provide shipping instructions within 30 days or the sample will be disposed of.External # (b)(4).Pv response: tue 2/15/2022 3:04 am: kindly note that there will be no late submission, because initial report (doin: (b)(6) 2021) for which the additional case was opened yesterday ((b)(4)) was considered as non-serious without patient identifiers and as such does not require submission to any regulatory authority.Based on the answers on fu questions received for the case (b)(4) (lrd: (b)(6) 2022), case was upgraded to serious and as such requires submission (due date: (b)(6) 2022).For additionally opened case ((b)(4)) follow-up will be opened as well (lrd: (b)(6) 2022) based on the above mentioned answers for the case (b)(4), because the reporter stated that both patients experienced the exact same event, and the case will also be submitted on time (due date: (b)(6) 2022).
 
Manufacturer Narrative
(b)(6) initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).No samples or photos were available for evaluation.As a result, bd was unable to verify the reported issue or determined a definitive root cause at this time.A production record review was completed for batch/lot 1177228 and no non-conformance was noted during the manufacturing of this lot.If a sample or photo becomes available, bd will re-open the record and investigate accordingly.No further action will be taken.This failure mode will continue to be tracked and trended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE STEP HI-LITE ORANGE
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION 213, LLC 0113
1550 northwestern dr
el paso TX 79912
Manufacturer (Section G)
CAREFUSION, INC
75 n. fairview drive
vernon hills IL 60061
Manufacturer Contact
anna wehrheim
75 n. fairview drive
vernon hills, IL 60061
8015652341
MDR Report Key13661261
MDR Text Key290941709
Report Number3004932373-2022-00063
Device Sequence Number1
Product Code KXG
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number930815
Device Lot Number1177228
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-